Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

书信:S.I.I. 这是一封信 单位单位单位单位单位单位.

C G Fraser

    Lancet (London, England)
    |June 8, 1974
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Scottish Bowel Screening Programme colonoscopy quality - scope for improvement?

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
    Same author

    Participation in bowel screening among men attending abdominal aortic aneurysm screening.

    The British journal of surgery·2018
    Same author

    Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
    Same author

    Low faecal haemoglobin concentration potentially rules out significant colorectal disease.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2012
    Same author

    The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study.

    British journal of cancer·2012
    Same author

    Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2011
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    Same journal

    Dual mobility total hip replacement in fractures: stability promotes patient confidence.

    Lancet (London, England)·2026
    Same journal

    Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

    Lancet (London, England)·2026
    查看所有相关文章